Nagendran Sukumar Insider Trades

Insider Trading History

Track insider trading activity for Nagendran Sukumar. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $3.13M 455,920 shares
Last Trade
Apr 10, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$85.4k 19,021 shares
$4.49
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $9.17M 1,336,410 shares
Last Trade
Apr 10, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$85.4k 19,021 shares
$4.49
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $7.8M 1,136,410 shares
Last Trade
Apr 10, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$892k 200,000 shares
$4.46
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $9.04M 1,317,389 shares
Last Trade
Jan 26, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$124k 26,918 shares
$4.61
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $9.22M 1,344,307 shares
Last Trade
Jan 23, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$423k 89,132 shares
$4.75
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $6.9M 1,006,439 shares
Last Trade
Jan 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$942k 200,000 shares
$4.71
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $3.26M 474,941 shares
Last Trade
Jan 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$972k 200,000 shares
$4.86
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $8.28M 1,206,439 shares
Last Trade
Jan 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$972k 200,000 shares
$4.86
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $9.83M 1,433,439 shares
Last Trade
Jan 12, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.41M 701,000 shares
$4.86
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $8.69M 1,266,486 shares
Last Trade
Dec 01, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.15M 260,047 shares
$4.43
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $3.87M 563,617 shares
Last Trade
Dec 01, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.15M 260,047 shares
$4.43
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $6.9M 1,006,439 shares
Last Trade
Dec 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.17M 260,047 shares
$4.51
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $6.9M 1,006,439 shares
Last Trade
Nov 28, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$523k 110,125 shares
$4.75
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $5.65M 823,664 shares
Last Trade
Nov 28, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$522k 110,125 shares
$4.74
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $7.66M 1,116,564 shares
Last Trade
Nov 28, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$522k 110,125 shares
$4.74
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $6.9M 1,006,439 shares
Last Trade
Sep 10, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$646k 200,000 shares
$3.23
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $8.28M 1,206,439 shares
Last Trade
Sep 10, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$134k 41,150 shares
$3.25
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $2.01M 292,855 shares
Last Trade
Sep 10, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$134k 41,150 shares
$3.25
$6.86
Taysha Gene Therapies
Taysha Gene Therapies TSHA
President And Head Of R&d
Holding Value $7.99M 1,165,289 shares
Last Trade
Aug 21, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$163k 57,054 shares
$2.85
$6.86
Solid Biosciences
Solid Biosciences SLDB
Director
Holding Value $681k 77,500 shares
Last Trade
Jun 12, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$355k 77,500 shares
$4.58
$8.79

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up